These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28131727)

  • 41. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesencephalic astrocyte-derived neurotrophic factor (MANF) prevents the neuroinflammation induced dopaminergic neurodegeneration.
    Zhang JX; Zhou KG; Yin YX; Jin LJ; Tong WF; Guo J; Yu LH; Ye XC; Jiang M
    Exp Gerontol; 2023 Jan; 171():112037. PubMed ID: 36436758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease.
    Gasmi M; Brandon EP; Herzog CD; Wilson A; Bishop KM; Hofer EK; Cunningham JJ; Printz MA; Kordower JH; Bartus RT
    Neurobiol Dis; 2007 Jul; 27(1):67-76. PubMed ID: 17532642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesencephalic astrocyte-derived neurotrophic factor alleviated 6-OHDA-induced cell damage via ROS-AMPK/mTOR mediated autophagic inhibition.
    Zhang J; Cai Q; Jiang M; Liu Y; Gu H; Guo J; Sun H; Fang J; Jin L
    Exp Gerontol; 2017 Mar; 89():45-56. PubMed ID: 28099881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease.
    Xue YQ; Ma BF; Zhao LR; Tatom JB; Li B; Jiang LX; Klein RL; Duan WM
    Gene Ther; 2010 Jan; 17(1):83-94. PubMed ID: 19727138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
    Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
    Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.
    Mandel RJ; Spratt SK; Snyder RO; Leff SE
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14083-8. PubMed ID: 9391156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.
    Petrova P; Raibekas A; Pevsner J; Vigo N; Anafi M; Moore MK; Peaire AE; Shridhar V; Smith DI; Kelly J; Durocher Y; Commissiong JW
    J Mol Neurosci; 2003 Apr; 20(2):173-88. PubMed ID: 12794311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
    Lapchak PA; Araujo DM; Hilt DC; Sheng J; Jiao S
    Brain Res; 1997 Nov; 777(1-2):153-60. PubMed ID: 9449424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
    Mandel RJ; Snyder RO; Leff SE
    Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.
    Eslamboli A; Georgievska B; Ridley RM; Baker HF; Muzyczka N; Burger C; Mandel RJ; Annett L; Kirik D
    J Neurosci; 2005 Jan; 25(4):769-77. PubMed ID: 15673656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease.
    Chen X; Liu W; Guoyuan Y; Liu Z; Smith S; Calne DB; Chen S
    Parkinsonism Relat Disord; 2003 Oct; 10(1):1-7. PubMed ID: 14499199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector.
    Georgievska B; Kirik D; Rosenblad C; Lundberg C; Björklund A
    Neuroreport; 2002 Jan; 13(1):75-82. PubMed ID: 11924898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.
    Vaudano E; Rosenblad C; Björklund A
    Eur J Neurosci; 2001 Jan; 13(1):1-14. PubMed ID: 11134999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.
    Bilang-Bleuel A; Revah F; Colin P; Locquet I; Robert JJ; Mallet J; Horellou P
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8818-23. PubMed ID: 9238061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.